SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently trending as members of the 'SHIB Army' rally to maintain momentum, with active discussions focusing on token burn mechanisms, comparisons to other meme coins, and potential long-term price appreciation. Community sentiment remains polarized between long-term bulls anticipating a massive breakout and skeptics who view the asset as a speculative gamble with a high circulating supply.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is facing heightened investor attention as the company approaches a pivotal Supreme Court hearing regarding patent litigation while concurrently preparing to report Q1 financial results. The community is actively debating the potential for a favorable legal outcome to stabilize U.S. market positioning, while some shareholders remain skeptical of management's ability to drive value through long-rumored product developments and strategic buyout opportunities.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing significant short-term bearish pressure and volatility as investors pivot away from high-valuation growth stocks, leading the community to debate whether current prices represent a generational buying opportunity or a deeper correction. While some investors remain fixated on the long-term potential of trapped-ion technology and the company's expanding manufacturing ecosystem, others are closely tracking the SkyWater merger progress and potential government contract catalysts that could stabilize the stock.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly anticipate upcoming Phase 3 IZAR-1 trial results, with significant community discussion focused on whether the data will be released this weekend or in the coming weeks. Bullish sentiment is being driven by speculation regarding potential M&A activity, institutional interest, and the belief that the drugs best-in-class efficacy will validate the company's platform as a major acquisition target.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors focus on its role in the real-world asset (RWA) tokenization space, with community discussions heavily debating its potential as a long-term utility play versus a speculative governance token. While some traders are reacting to short-term price volatility and technical patterns, many are focused on the broader adoption of tokenized treasuries and the impact of future legislative clarity on the ecosystem.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is experiencing significant volatility and social media attention as investors debate the impact of potential tariff relief, the successful integration of the Rhode brand, and the stock's role as a consumer-staple hedge against tech sector instability. Community sentiment remains polarized between aggressive bulls who are 'loading the boat' at perceived support levels and skeptics who highlight technical weakness and lingering margin concerns.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently facing significant downward pressure as investors rotate out of defensive stocks and react to persistent concerns over consumer spending and menu pricing. While some traders are attempting to play the stock for a potential value-based rebound, the community remains divided, with bearish voices citing a weakening technical outlook while others highlight its long-term dividend reliability.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending due to significant profitability growth in its CSI Solar subsidiary and anticipation surrounding the upcoming earnings report. The community remains focused on potential short squeeze dynamics driven by high short interest, alongside discussions regarding the company's US manufacturing expansion and its role in meeting the surging energy demand from AI data centers.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is seeing significant investor attention driven by upcoming topline results from its Phase 3 Emerge study, which many in the community view as a potential catalyst for valuation growth. While bullish sentiment centers on the drug's therapeutic potential, discussions are heavily balanced by concerns over historical dilution, the heavy capital burn rate required for concurrent clinical trials, and skepticism from some market participants regarding the company's long-term profitability.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum Inc. (QNT) is trending as it completes a highly anticipated IPO, with community sentiment split between excitement over its strong institutional backing and concerns regarding its premium valuation compared to other quantum players. Traders are actively debating the stock's long-term potential as the sector faces intense scrutiny over revenue generation versus long-term technological milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo

BioMarin's FDA filing for full Voxzogo approval in achondroplasia has been accepted, with a regulatory decision expected by Feb. 28, 2027.

BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth

BBIO builds on Attruby's launch as rising rare disease diagnoses and late-stage pipeline candidates set up multiple potential U.S. launches.

Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead

BridgeBio Pharma's Attruby sales are surging, but can growth keep justifying its premium valuation amid execution risks and rising costs?

Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last?

Ascendis Pharma (ASND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

BMRN's shares rise after Voxzogo hits the main goal in a late-stage hypochondroplasia study, supporting planned FDA filings in 2026.

Growth Stocks To Keep An Eye On - May 6th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Pershing Square, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings faster...

Morse Asset Management Inc Purchases Shares of 6,489 Ascendis Pharma A/S $ASND

Morse Asset Management Inc purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities...

Growth Stocks To Follow Now - May 4th

Prologis, Pershing Square, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, and Tyra Biosciences are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings...

Growth Stocks To Follow Now - May 3rd

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Acadia Realty Trust are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to increase revenue and earnings faster than the overall market, ofte...

Best Growth Stocks To Consider - May 2nd

Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to...

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S

Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASNDAscendis Pharma

Fundamentals

Latest ASND News